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Abstract
Autophagy is a dynamic cellular pathway involved in 
the turnover of proteins, protein complexes, and or-
ganelles through lysosomal degradation. The integrity 
of postmitotic neurons is heavily dependent on high 
basal autophagy compared to non-neuronal cells as 
misfolded proteins and damaged organelles cannot be 
diluted through cell division. Moreover, neurons con-
tain the specialized structures for intercellular commu-
nication, such as axons, dendrites and synapses, 
which require the reciprocal transport of proteins, or-
ganelles and autophagosomes over significant dis-
tances from the soma. Defects in autophagy affect the 
intercellular communication and subsequently, con-
tributing to neurodegeneration. The presence of ab-
normal autophagic activity is frequently observed in 
selective neuronal populations afflicted in common 
neurodegenerative diseases, such as Alzheimer’s dis-
ease, Parkinson’s disease, Huntington’s disease and 
amyotrophic  lateral  sclerosis.  These  observations 
have provoked controversy regarding whether the in-
crease in autophagosomes observed in the degenerat-
ing neurons play a protective role or instead contribute 
to pathogenic neuronal cell death. It is still unknown 
what factors may determine whether active autophagy 
is beneficial or pathogenic during neurodegeneration. 
In this review, we consider both the normal and patho-
physiological roles of neuronal autophagy and its po-
tential therapeutic implications for common neuro-
degenerative diseases.
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Introduction
Neurons have highly specialized structures for in-
tercellular communication, which typically include 
the axon, dendrites and synapses (Figure 1). In 
particular, the axon transfers proteins and organelles 
over significant distances in the nervous system. 
Almost all the materials contained in the axon origi-
nate in the soma and are localized to the axon via 
axoplasmic transport, in which the constant quality 
control of proteins and mitochondria is critical for 
proper neuronal function. Synapses represent re-
gions of high energy demand and protein turnover; 
they contain abundant mitochondria and poly-
ribosomes which make them more susceptible to 
the consequences of dysfunctional autophagy. In 
addition, the fact that neurons are postmitotic and 
do not replicate in general might predispose them 
to the accumulation of toxic proteins and damaged 
organelles inside neurons that could become di-
luted through cell division in replicating cells. 
     The critical importance of tightly controlled pro-
teins and organelles in the neurons suggests that 
neuronal autophagy may be regulated distinctively 
from that of non-neuronal cells. In accordance with 
this notion, a study using GFP-LC3 transgenic 
mouse model demonstrated that autophagy is dis-
tinctly regulated in neurons (Mizushima et al., 
2008). Other work has revealed significant differ-
ences in basal autophagy between neuronal and 
non-neuronal cells (Mitra et al., 2009). Recent 
loss-of function studies demonstrate a critical role 
for basal autophagy in the removal of damaged 
proteins and organelles in specific neurons of the 
brain (Hara et al., 2006; Komatsu et al., 2006).
     Intracellular protein aggregates and dysfunctional 
organelles are common features of neurodegenera-
tive diseases, such as Alzheimer’s disease (AD), 90    Exp. Mol. Med. Vol. 44(2), 89-98, 2012
Figure 1. The basic and pathogenic role of neuronal autophagy. Neurons have highly specialized structures for intercellular communication, which typi-
cally include the soma, axon, dendrites and synapses. In the soma, the central region of the neuron containing the nucleus, basal levels of autophagy, in-
cluding macroautophagy, mitophagy and chaperone-mediated autophagy (CMA), occur to maintain normal cellular homeostasis. The axon, a specialized 
structure to conduct nerve impulses, transfers proteins and organelles over significant distances by axoplasmic transport. Axotomy and excitotoxic insult 
trigger the accumulation of autophagosomes in dystrophic axonal swellings. Autophagic vaculoes (AVs) have also been observed in dysfunctional axons 
in alzheimer’s disease (AD), parkinson’s disease (PD) and huntington’s disease (HD). Synapse, the region of contact where a neuron transferring in-
formation to another cell, represents a region of high energy demand and protein turnover; They contain abundant mitochondria and polyribosomes. 
Autophagy is known to play an important role in synapse development as autophagy is induced in response to many developmental and environmental 
cues. Thus, autophagy may play an important role in the synapse growth and plasticity required for learning and memory. 
Parkinson’s disease (PD), Huntington’s disease 
(HD) and amyotrophic lateral sclerosis (ALS). 
Subsequently, in the course of these diseases, 
toxic protein aggregates and damaged organelles 
accumulate within specific types of neurons and 
lead to neuronal dysfunction and ultimate neuronal 
death (Figure 2). Therefore, the precise and localized 
activation of autophagy in soma, axons or synapses 
may represent a beneficial therapeutic intervention 
for neurodegenerative diseases, even though potential 
pathogenic contribution of activated autophagy must 
be carefully monitored. 
Characteristics of neuronal autophagy in 
the synapse and axon
Autophagy in synapse development 
Neuronal autophagy plays an important role in 
synapse development. A recent study demonstrates 
that decreasing or increasing autophagy results in 
corresponding effects on synapse size (Shen and 
Ganetzky, 2009). They found that neuronal autophagy 
positively regulates synaptic development in the 
Drosophila neuromuscular junction. Overexpression 
of Atg1, a serine/threonine kinase and key regulator 
of autophagy, is sufficient to induce high levels of 
autophagy and subsequent enhancement of synaptic 
growth. In contrast, reducing autophagy activity 
through mutations in autophagy genes results in the 
reduction of synapse size. The ubiquitin-proteasome 
pathway system (UPS) is known to be an important 
negative regulator of synaptic development in the 
neuromuscular junction (Wan et al., 2000). Neuronal 
autophagy and UPS converge to regulate synapse 
development by regulating Hiw, an E3 ubiquitin 
ligase. Of interest, Atg1 is suggested to play a role 
in the regulation of synaptic structure via the 
downregulation of the MAP kinase ERK activity 
(Wairkar  et al., 2009). In mice carrying an Atg1 
mutation, synaptic density was decreased by 
excessive ERK activity, suggesting that activated 
ERK negatively regulates synapse formation. As 
autophagy is induced in response to many develop-
mental and environmental cues, neuronal autophagy 
may play an important role in the synapse growth 
and plasticity required for learning and memory. 
Axonal autophagy in injured neurons
The axon is a highly specialized structure dedicated 
to information transfer over sometimes lengthy 
distances in the nervous system. Autophagy has 
previously been suggested to be associated with 
axonal dystrophy following axotomy or excitotoxic 
stimuli. For instance, after axotomy, autophagosome- 
like vesicles accumulate in axon terminals (Dixon, 
1967; Mattews and Raisman, 1972). This increased Neuronal autophagy and neurodegenerative diseases    91
Figure 2. Disease causing proteins affecting various types of autophagy in common neurodegenerative diseases. Familial forms of the common neuro-
degenerative diseases, such as AD, PD, HD and ALS, are caused by gene mutations, which affect different types and steps of autophagy. AD is charac-
terized by the pathogenic accumulation of amyloid plaques consisting of β-amyloid (Aβ) peptides generated by proteolytic cleavage of amyloid precursor 
protein (APP). AVs are a major reservoir of intracellular Aβ in the brain. Mutant presenilin 1 (PS1) impairs autophagosome clearance, resulting in en-
hanced Aβ accumulation in AD. PD is characterized by the presence of Lewy bodies, the intracytoplasmic inclusions containing α-synuclein, which is de-
graded by macroautophagy and CMA. The inhibition of CMA leads to an accumulation of soluble high molecular weight and detergent-insoluble species of 
α-synuclein and the inhibition of macroautophagy also leads to the accumulation of wild type α-synuclein. Mitochondrial dysfunction has been implicated 
in the pathogenesis of PD. PINK1 and parkin mediate the removal of mitochondria by mitophagy, of which mutations result in the accumulation of impaired 
mitochondria. HD is characterized by the presence of inclusion bodies composed of the N-terminal fragment of mutant Htt, which is associated with the 
primary defect in the ability of autophagic vacuoles to recognize cytosolic cargo. Mutations in the SOD1gene underlie 20% of familial ALS cases. Agents 
promoting autophagy, such as lithium and rapamycin, help autophagic clearance of mutant SOD1.
autophagy is accompanied by chromatolysis, a 
term that describes an area of cytoplasm that is 
devoid of organelles and filled with various types of 
vesicles including autophagosomes (Dixon, 1967). 
Similarly, in Purkinje cells of the Lurcher mouse, a 
model of excitotoxic neurodegeneration, excitotoxic 
insults trigger the accumulation of GFP-LC3-labeled 
autophagosomes in dystrophic axonal swellings, a 
hallmark of CNS axonopathy (Wang et al., 2006). 
Autophagosome-like vesicles have also been 
observed in dysfunctional axons in AD, PD and HD 
(Roizin et al., 1974; Anglade et al., 1997; Nixon et 
al., 2005).
Autophagy in Alzheimer’s disease
AD is the most common form of senile dementia. 
AD is characterized by the pathogenic accumulation 
of amyloid plaques consisting of β-amyloid (Aβ) 
peptides, which are generated by the sequential 
cleavage of amyloid precursor protein (APP) via the 
β-secretase and γ-secretase, and by the intracellular 
accumulation of neurofibrillary tangles containing 
hyperphosphorylated tau (Vassar et al., 1999). 
Electron microscopy studies on AD brain provided 
the first evidence that autophagy is extensively 
involved in the neurodegenerative process (Nixon 
et al., 2005). Autophagic vacuoles (AVs) were 
abundant in AD brains, particularly, within dystrophic 
neuritis. Autophagy was also evident in the perikarya 
of affected neurons, especially in those with neu-
rofibrillary tangles. The significant accumulations of 
immature AV forms in dystrophic neurites suggest 
that the transport of AVs and their maturation to 
lysosomes, may be impaired in AD. Subsequently, 
immunolabeling studies identified AVs in the brain 
to be a major reservoir of intracellular Aβ (Yu et al., 
2005). Purified AVs contain both full-length APP 
and  β-secretase cleaved APP and are highly 
enriched in the γ-secretase complex subunits 
presenilin-1 (PS1) and nicastrin. In addition, the 
mammalian target of rapamycin (mTOR) kinase- 
mediated modulation of autophagy in neuronal 
cells elicits parallel changes in AV proliferation and 
Aβ production. These data suggest a direct link 92    Exp. Mol. Med. Vol. 44(2), 89-98, 2012
between β-amyloidogenic and cell survival pathways 
via activated autophagy in AD.
     Autophagosomes and endosomes within neurons 
actively form in synapses and along neuritic proc-
esses; however, their efficient clearance requires 
their retrograde transport towards the soma, which 
contains the highest concentration of lysosomes. 
In AD the maturation of autophagolysosomes and 
their retrograde transport are impaired, which re-
sults in a massive accumulation of AVs within de-
generating neurites. This combination of increased 
autophagy induction and defective clearance of 
Aβ-generating AVs results in Aβ accumulation 
(Nixon, 2007; Boland et al., 2008). Furthermore, 
defective lysosomal proteolysis may underlie fur-
ther pathogenic protein accumulations and neuro-
nal cell death in AD. The AD-related protein PS1 is 
required for autophagy and in neurons from mice 
hypomorphic for PS1, autophagosome clearance 
is prevented as a result of the selective impairment 
of autolysosome acidification and cathepsin activa-
tion, which are caused by the failure of PS-1-de-
pendent targeting of v-ATPase subunit to lyso-
somes (Lee et al., 2010). N-glycosylation of the 
v-ATPase subunit is essential for its efficient 
ER-to-lysosome delivery, which requires the se-
lective binding of PS1 to its unglycosylated subunit. 
Similarly, PS1 mutations responsible for early-on-
set AD produce a defective lysosomal/autophagy 
phenotype in fibroblasts of AD patients. These 
phenomena could be explained by the fact that 
PS1 is essential for the targeting of v-ATPase sub-
unit to lysosomes, lysosome acidification, and pro-
teolysis during autophagy (Cataldo et al., 2004; 
Lee et al., 2010). These findings show that the im-
pairment of autophagosome maturation could lead 
to the increased accumulation of Aβ in AD. 
     Beclin1, also known as Atg6, is a proautophagic 
protein. The protein Beclin1 expression decreases 
in aged human brain, leading to a reduction of 
autophagy with aging. Beclin 1 has been shown to 
be decreased in the AD brains (Pickford et al., 2008). 
Decreased neuronal autophagy and subsequent 
neurodegeneration is observed in mice carrying a 
heterozygous deletion of beclin 1 (Pickford et al., 
2008). In the APP transgenic mouse model of AD, 
the reduced expression of beclin1 results in an 
increase of intraneuronal Aβ accumulation, ex-
tracellular Aβ deposition and neurodegeneration, 
which was ameliorated by the lentiviral expression 
of beclin 1 (Pickford et al., 2008). Moreover, beclin1 
deficiency has been shown to disrupt cellular auto-
phagy and autophagosomal-lysosomal degradation 
and to alter APP metabolism (Jaeger et al., 2010). 
These studies suggest that reduced autophagy via 
beclin1 deficiency might reduce Aβ clearance; 
therefore, increasing beclin 1 levels may have a 
therapeutic potential in AD. 
     The mTOR pathway plays an essential role in 
neuronal functions by controlling protein homeostasis. 
mTOR signaling has been shown to regulate 
various forms of learning and memory. In an 
animal model of AD, the pharmacological inhibition 
of mTOR signaling with rapamycin rescues cognitive 
deficits and ameliorates Aβ and tau pathology by 
increasing autophagy (Caccamo et al., 2010). 
Similarly, the long-term inhibition of mTOR by 
rapamycin prevents AD-like cognitive deficits and 
lowered levels of Aβ in the PDAPP transgenic 
mouse model (Spilman et al., 2010). These results 
provide a molecular basis for the efficacy of mTOR 
inhibition in ameliorating cognitive impairment in AD 
models by demonstrating that the resultant increased 
autophagy results in the reduction in Aβ and the 
improvement in cognitive function. These obser-
vations collectively suggest that autophagy plays a 
critical role in the pathogenesis of AD and that the 
inhibition of mTOR signaling and/or the activation 
of beclin 1 signaling may reduce Aβ and tau 
pathology, subsequently improving learning and 
memory in AD patients.
Autophagy in Parkinson’s disease 
PD is one of the most common neurodegenerative 
disorders. PD is caused by the selective cell death 
of dopamine neurons in the substantia nigra (SN) 
and is characterized by the presence of Lewy 
bodies, which are the intracytoplasmic inclusions 
containing  α-synuclein and ubiquitin. Early ultra-
structural examinations in PD patients revealed 
characteristics of apoptosis and autophagy in the 
degenerating melanized neurons of the SN 
(Anglade et al., 1997). Subsequently, the pathogenic 
role of autophagy in PD was demonstrated by the 
finding that α-synuclein, a major constituent of 
Lewy body, is degraded by macroautophagy and 
chaperone-mediated autophagy (CMA) (Webb et 
al., 2003; Cuevo et al., 2004; Vogiatzi et al., 2008). 
The inhibition of CMA leads to an accumulation of 
soluble high molecular weight and detergent-insoluble 
species of α-synuclein and the inhibition of 
macroautophagy also leads to the accumulation of 
wild type α-synuclein, suggesting that CMA and 
macroautophagy are important pathways for wild 
type α-synuclein degradation in neurons (Vogiatzi 
et al., 2008). In addition, beclin 1 plays an 
important role in the intracellular degradation of 
α-synuclein either directly or indirectly through the 
autophagic pathway. When a lentivirus expressing 
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transgenic mouse, the synaptic and dendritic 
pathology was ameliorated and the accumulation 
of α-synuclein in the limbic system was reduced 
(Spencer et al., 2009). These results were accom-
panied by enhanced lysosomal activation and a 
reduction in deficits in the autophagy pathway. 
     The familial PD-associated molecules, such as 
the wild type, A53T and A30P mutants of α-synuclein, 
DJ-1, parkin, PINK1 and LRRK2 are known to be 
involved in the autophagic pathway. For instance, 
overexpression of wild type α-synuclein impairs 
macroautophagy both in vitro, in mammalian cells 
and  in vivo, in transgenic mice because multi-
plication of the α-synuclein gene locus is known to 
increase α-synuclein expression and cause familial 
PD (Winslow et al., 2010). α-Synuclein over-
expression causes the mislocalization of the 
autophagy protein, Atg9, and decreased formation 
of omegasome. Both α-synuclein, and Atg9 regulate 
formation of the omegasomes, marking autophago-
some precursors. Of interest, A53T and A30P 
mutants inhibit CMA via a higher binding affinity for 
the lysosomal-associated membrane protein 2A 
(LAMP2A) compared with wild type α-synuclein 
(Cuevo  et al., 2004; Xilouri et al., 2009). Over-
expression of both mutant and wild type α-synuclein 
is accompanied by the induction of compensatory 
macroautophagy. The mutant α-synuclein is degraded 
by macroautophagy instead of CMA. Therefore, 
impaired CMA might trigger neuronal death and 
the preservation of proper CMA activity could be a 
potential target for PD therapeutics. The functional 
deficiency of DJ-1, a recessive familial PD gene, 
also leads to altered autophagy (i.e. increased 
autophagic flux) in murine and human cells (Irrcher 
et al., 2010). In addition, mutations in the leucine- 
rich repeat kinase 2 (LRRK2) have been implicated 
in both autosomal dominant and some cases of 
sporadic PD. Cells transfected with G2019S LRRK2 
mutant exhibit striking increases of autophagic 
vacuoles in both neuritic and somatic compartments 
(Plowey et al., 2008). Knockdown of LC3 or Atg7, 
two essential components of the autophagic 
machinery, reversed the effects of G2019S LRRK2 
expression on neuronal process length, whereas 
rapamycin potentiated these effects, suggesting 
that the pathogenic mutation of LRRK2 plays 
active role for autophagy in neurite remodeling. 
Mutations in the PTEN-induced putative kinase 1 
(PINK1) gene also cause autosomal recessive PD. 
The full-length PINK1 interacts with Beclin1 and the 
overexpression of PINK1 significantly enhances 
both basal and starvation-induced autophagy, 
which can be reduced by beclin1 gene knockdown. 
Of interest, the W437X mutant of PINK1 
demonstrates an impaired interaction with Beclin1 
and lacks the ability to induce autophagy, whereas 
the G309D mutant of PINK1, which has defective 
kinase activity, does bind with Beclin1 (Michiorri et 
al., 2010). 
     Although neuronal autophagy appears primarily 
to be a protective process in the nervous system, it 
can also play a paradoxical role in neuronal death. 
With respect to the role of autophagy in neuronal 
death, several studies employing PD toxins, a 
mutant familial PD gene and postmortem PD 
brains have demonstrated an important role for 
autophagy in promoting the death of dopamine 
neurons. For example, autophagic cell death has 
been observed in nigral dopamine neurons of PD 
patients (Anglade et al., 1997). MPP
+ or dopamine 
toxicity-induced oxidative stress, increases the 
number of AVs, autophagy and cell death, all of 
which differs from what is observed in starvation- 
induced autophagy (Gomez-Santos et al., 2003; 
Zhu  et al., 2007). Oxidative stress, a major 
pathogenic mechanism of PD, has been shown to 
increase autophagic cell death in dopaminergic 
neurons by suppressing the expression of Oxi-α 
gene, which encodes a novel mTOR activator 
(Choi  et al., 2010). The Oxi-α gene knockdown 
resulted in not only the repression of mTOR kinase 
activity, but also enhances neuronal susceptibility 
to oxidative stress. In agreement with these 
observations, treatment with rapamycin, an mTOR 
inhibitor and autophagy inducer, potentiates cell 
death induced by oxidative stress. In addition, 
overexpression of the A53T mutant of human 
α-synuclein induces an accumulation of AVs and 
autophagic cell death (Stefanis et al., 2001; Kirik et 
al., 2002; Xilouri et al., 2009; Yang et al., 2009). 
These studies suggest that pathogenic autophagy 
associated with neuronal death does occur and 
may be distinct from basal neuronal autophagy. 
The contribution of autophagy and autophagic cell 
death to degeneration of dopamine neurons may 
vary depending on the initial cause and specific 
cellular context. A better understanding of autophagic 
stress (Chu, 2006) and further identification of 
autophagic cell death mechanisms may lead to 
therapeutics that help restore homeostasis to 
dopamine neurons in PD. 
     Damaged  mitochondria  accumulate  with  age 
and mitochondrial dysfunction has been implicated 
in the pathogenesis of PD. Previously, recessive 
mutations in parkin, an ubiquitin E3 ligase, have 
been identified as a cause of early onset, familial 
PD,. However, the precise role of parkin in 
mitochondria is unknown. It was recently shown 
that parkin is selectively recruited to damaged 
mitochondria, which have low membrane potential 
in mammalian cells. Following recruitment, parkin 94    Exp. Mol. Med. Vol. 44(2), 89-98, 2012
Figure 3. PINK1 and parkin-mediated mitophagy. In the current model of 
the PINK1/parkin-mediated mitophagy, PINK1, implicated in familial PD, 
is normally maintained at low levels on mitochondria by voltage-dependent 
proteolysis, which is mediated by the mitochondrial presenilin-associated 
rhomboid-like protein (PARL) present in the inner mitochondrial membrane. 
In the absence of PARL, the constitutive degradation of PINK1 is in-
hibited and a 60-kD form of PINK1 is stabilized inside mitochondria. 
When the mitochondrial membrane potential is dissipated, PINK1 accu-
mulates as a 63-kD full-length form in the outer mitochondrial membrane. 
Thus, accumulation of mitochondrial damage by gene mutations or car-
bonyl cyanide m-chloro phenyl hydrazone (CCCP), a mitochondrial un-
coupling agent, facilitates the rapid accumulation of PINK1 and the sub-
sequent PINK1 accumulation in the mitochondria recruits parkin to ubiq-
uitinate VDAC (and/or mitofusin) on the mitochondrial outer membrane, 
which becomes a target for mitophagy. The ubiquitin-binding adaptor p62 
(also known as sequestosome 1) recruits ubiquitinated cargo into auto-
phagosomes by binding to LC3.
mediates the removal of mitochondria by autophagy 
and the selective elimination of impaired mitochondria 
(Narendra et al., 2008). This discovery revealed a 
link between the mitochondrial quality control and 
proteins mutated in familial PD, and further 
implicates a failure to eliminate dysfunctional 
mitochondria in the pathogenesis of PD. 
     The  link  between  parkin  and  mitophagy  has 
brought about great interest in the molecular 
mechanism of mitophagy as well as the pathogenic 
role of mitophagy in PD (Figure 3). Of interest, 
PINK1, a mitochondrial serine/threonine kinase, also 
implicated in familial PD, is normally maintained at 
low levels on mitochondria by voltage-dependent 
proteolysis (Narendra et al., 2010), mediated by 
the mitochondrial presenilin-associated rhomboid-like 
protein (PARL) present in the inner mitochondrial 
membrane (Jin et al., 2010). In the absence of 
PARL, the constitutive degradation of PINK1 is 
inhibited and a 60-kD form of PINK1 is stabilized 
inside mitochondria. When the mitochondrial 
membrane potential is dissipated, PINK1 accumulates 
as a 63-kD full-length form in the outer mitochondrial 
membrane. Thus, damage to mitochondria facilitates 
the rapid accumulation of PINK1 and the subsequent 
PINK1 accumulation in the mitochondria recruits 
parkin to induce mitophagy (Narendra et al., 2010; 
Geisler et al., 2010). At this stage, the autophagic 
adaptor protein p62/SQSTM1 is recruited to 
mitochondria, which may be important for the 
clearance of mitochondria (Figure 3). In addition, 
the voltage-dependent anion channel 1 (VDAC1) is 
a target for parkin-mediated poly-ubiquitylation of 
Lys 27 and mitophagy (Geisler et al., 2010). Thus, 
pathogenic parkin mutations, together with PINK1 
mutations, could lead to the disruption of 
mitochondrial recruitment of parkin, ubiquitination 
of mitochondrial substrates, formation of AVs and 
the final clearance of damaged mitochondria via 
mitophagy. Consistent with this notion, a detailed 
analysis of PINK1 and parkin knockout models 
revealed an accumulation of damaged mitochondria 
in various tissues including dopamine neurons 
(Greene et al., 2003; Gautier et al., 2008; Shim et 
al., 2011). These observations suggest that neuronal 
autophagy is essential for the turnover of damaged 
mitochondria in PD and that the failure to induce 
mitophagy may underlie the selective dopaminergic 
neuronal loss observed in PD. Thus, stimulating 
the proper induction of mitophagy in dopaminergic 
neurons may serve as a therapeutic target to slow 
disease progression in PD.
Autophagy in Huntington’s disease 
HD, an autosomal dominant movement disorder, is 
caused by the expansion (＞35 repeats) of CAG 
trinucleotide repeats in the huntingtin (htt) gene, 
which encodes an expanded polyglutamine (poly(Q)) 
tract in the N-terminus of the Htt protein. The 
toxicity of the mutant Htt protein is believed to result 
from the intraneuronal aggregates of the N-terminal 
fragments, the typical pathological hallmark of HD. 
The characteristic features of altered autophagy 
were first observed in postmortem brains of HD 
patients (Tellez-Nagel et al., 1974). In the models of 
HD, when mutant Htt was exogenously expressed 
in striatal neurons, mutant Htt-labeled vacuoles 
displayed the ultrastructural features of autophago-
somes. In addition, neurons with excess cytoplasmic 
Htt exhibited an increased tubulation of endosomal 
membranes (Kegel et al., 2000). Thus, the 
accumulation of mutant Htt might activate the 
endosomal-lysosomal system and contribute to an Neuronal autophagy and neurodegenerative diseases    95
autophagic process of cell death. The involvement 
of autophagy in HD was further demonstrated by 
the sequestration of mTOR in polyglutamine 
aggregates in cell models, transgenic mice and 
human brains. The sequestration of mTOR impairs 
its kinase activity and induces autophagy. This 
autophagy protects against polyglutamine toxicity, 
as rapamycin attenuates Htt accumulation and cell 
death in cell models of HD and the inhibition of 
autophagy has the opposite effects (Ravikumar et 
al., 2004). Subsequently, a number of studies 
probed the therapeutic potential of autophagy 
induction in various models of HD (Ravikumar et 
al., 2003, 2004; Sakar et al., 2007). 
     The precise mechanism that underlies autophagic 
dysfunction in HD is poorly understood. The 
inefficient engulfment of cytosolic components by 
autophagosomes has been proposed to be 
responsible for their slower turnover and the 
accumulation of Htt in HD cells. Using cellular and 
mouse models of HD and cells from HD patients, a 
primary defect in the ability of autophagic vacuoles 
to recognize cytosolic cargo, was identified in HD 
cells. Autophagic vacuoles formed at normal rates 
and were adequately eliminated by lysosomes, 
however, they failed to efficiently trap cytosolic 
cargo in their lumen (Matinez-Vincente et al., 2010). 
Another mechanism underlying the intracellular 
accumulation of mutant Htt is that the accumulated 
mutant Htt recruits beclin 1 and impairs the beclin 
1-mediated long lived protein turnover. Thus, the 
sequestration of beclin 1 in the vulnerable neuronal 
population of HD patients might further reduce 
beclin 1 function and autophagic degradation of 
mutant Htt (Shibata et al., 2006). As beclin 1 
expression decreases in an age-dependent fashion 
in the human brains and the heterozygous deletion 
of beclin 1 gene is insufficient for the regulation of 
autophagosomes, it has been proposed that the 
age-dependent decrease of beclin 1 expression 
may lead to a reduction of autophagic activity, 
which in turn promotes the accumulation of mutant 
Htt and the progression of the disease (Shibata et 
al., 2006). 
     One homeostatic function of the wild type Htt 
protein has been proposed to be to act as an 
endoplasmic reticulum (ER) sentinel, regulating 
autophagy in response to ER stress (Atwal et al., 
2008). As a result, cells expressing mutant Htt may 
have perturbed ER function and have increased 
autophagic vesicles. Moreover, a number of findings 
suggest that the Htt protein exhibits structural and 
functional similarities to the central autophagy 
regulator, mTOR. For instance, Htt and mTOR are 
both scaffolding proteins and contain similar 
leucine-rich repeats, termed HEAT domains (Andrade 
and Bork, 1995). Both Htt and mTOR use amino- 
terminal HEAT repeats to specifically recognize 
membranous structures. In this way, mTOR reversibly 
associates with ER and Golgi membranes (Drenan 
et al., 2004). Similarly, Htt reversibly associate with 
ER and autophagic vesicles (Omi et al., 2005). As 
a result, cells expressing mutant Htt may have a 
perturbed ER and an increase in AVs (Atwal et al., 
2008). Therefore, these observations imply a 
potential role of Htt in the regulation of autophagy.
     The  initial  increase  in  AVs  and  autophagy 
observed in HD models may represent an attempt 
to remove mutant Htt protein and over time the 
autophagy machinery becomes dysfunctional, 
leading to neurodegeneration. Thus, the therapeutic 
induction and recovery of autophagy might may 
enhance the clearance of mutant Htt protein and 
reduce its toxic effect in HD neurons.
Autophagy in amyotrophic lateral sclerosis
ALS is a progressive neurodegenerative disorder 
that selectively affects motor neurons. Approximately 
10% of ALS cases are familial ALS (fALS) and, 
mutations in the Cu, Zn-superoxide dismutase 
(SOD1) gene underlie 20% of fALS cases, 
suggesting its crucial role in the pathogenesis of 
fALS. Although various pathogenic mechanisms 
have been proposed for ALS, a possible role for 
autophagy was observed in transgenic mouse 
models of fALS. For instance, in the transgenic 
SOD1G93A mouse, increased autophagy was 
observed during the presymptomatic stage (＜90 
days of age). Surprisingly, any significant changes 
in autophagy in the soma of motor neurons were 
not observed until the terminal stage in these mice 
(140 days of age) (Li et al., 2008). Another study 
also demonstrated that autophagosome formation 
was increased at the symptomatic stage and the 
percentage of motor neurons that contained 
phosphorylated mTOR/Ser2448 was decreased in 
the SOD1G93A transgenic mice (Morimoto et al., 
2007), which suggests the possibility that increased 
and/or impaired autophagy underlies pathological 
phenomena in this model. Much uncertainty still 
remains on the pathogenic mechanisms underlying 
motor neuron degeneration in ALS; Riluzole is the 
only available drug for the treatment of ALS and 
has marginal effects on disease survival. A number 
of putative therapeutic agents have recently been 
investigated for their potential role in neuropro-
tection (Siciliano et al., 2010). Among these, agents 
promoting autophagy, such as lithium and rapamycin, 
have been suggested to be effective for the 
survival of motor neurons in ALS by autophagic 96    Exp. Mol. Med. Vol. 44(2), 89-98, 2012
clearance of SOD1. Additional studies to address 
the precise pathogenic mechanism of autophagy in 
motor neuron death are essential for the iden-
tification of therapeutic targets in ALS.
Conclusion
Mounting evidence has firmly established the 
importance of neuronal autophagy in both the 
normal functioning and patho-physiological conditions, 
of the brain. Neuronal integrity is more sensitive to 
alterations in basal autophagy than that of 
non-neuronal cells due to their postmitotic nature 
and the specialized structures necessary for 
intercellular communications. Impairments in the 
quality control of proteins and organelles in the 
neuronal soma, axon and synapses likely disrupt 
normal neuronal function due to the accumulation 
of toxic protein aggregates and damaged 
organelles, ultimately leading to neurodegenerative 
conditions observed in diseases, such as AD, PD, 
HD and ALS. However, the cellular factors 
underlying homeostatic vs. pathogenic activation of 
autophagy have not been identified, nor is it 
understood how dysfunctional autophagy leads to 
neuronal death. Under certain pathophysiological 
conditions autophagy may represent a cell death 
mechanism via excessive removal of key survival 
factors or cellular organelles. More importantly, 
protein aggregates and damaged organelles picked 
up by autophagosomes in axon and synapses 
must be transported over distances to lysosomes 
in the soma, which implies the involvement of 
complex processes in neuronal autophagy. Therefore, 
an improved understanding of neuronal autophagy 
will provide novel insights into the pathogenic 
mechanisms of dysfunctional autophagy that 
underlie common neurodegeneratives diseases and, 
ultimately, help develop therapeutic interventions 
for autophagic dysregulation.
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